AGP Executive Report
Last update: 12 hours agoDrug Policy Spotlight (Mauritius): Mauritius’ National Agency for Drug Control chief Kunal Naik says the country’s drug situation is “critical,” arguing that arrests alone can’t measure progress and that Mauritius must strengthen prevention, harm reduction, treatment and rehabilitation alongside enforcement. Public Health Funding & Disease Control (Africa): WHO says several African countries, including Mauritius, have still hit major disease-elimination milestones despite the deepest cuts to global health financing in a generation, highlighting continued progress on HIV and tuberculosis care. Imported Disease Watch (Europe): Hungary reports a lab-confirmed imported chikungunya case in a traveller who was in Mauritius during the incubation period, underlining the need for mosquito-bite prevention and travel-related surveillance. Local Health Systems & Training (Regional): IIT Madras Zanzibar is running a new training programme for African government auditors on data science, AI and cybersecurity—relevant for strengthening how health and public services are monitored. Health-Adjacent Innovation (Global): A new “Ozempic for the brain” drug concept is being discussed for potential use in multiple brain conditions, following earlier narcolepsy approvals.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.